Gabather AB (publ) (GABA) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.117x

Based on the latest financial reports, Gabather AB (publ) (GABA) has a cash flow conversion efficiency ratio of -0.117x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-331.00K ≈ $-35.62K USD) by net assets (Skr2.82 Million ≈ $303.48K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Gabather AB (publ) to measure how many days the company can operate on defensive assets alone.

Gabather AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Gabather AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Gabather AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gabather AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bonyf NV PA:MLBON	0.545x
Invion Ltd AU:IVX	-0.163x
Aethlon Medical Inc NASDAQ:AEMD	0.000x
OurLiving AB ST:OURLIV	-4.139x
Thrive Tribe Technologies Ltd AU:1TT	-1.889x
NAYA Biosciences, Inc NASDAQ:NAYA	-0.048x
China Pharma Holdings Inc NYSE MKT:CPHI	-0.028x
PolyPlank publ AB ST:POLY	0.323x

Annual Cash Flow Conversion Efficiency for Gabather AB (publ) (2014–2025)

The table below shows the annual cash flow conversion efficiency of Gabather AB (publ) from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Gabather AB (publ) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-863.00K ≈ $-92.87K	Skr-7.22 Million ≈ $-777.42K	8.371x	+950.12%
2024-12-31	Skr-4.17 Million ≈ $-449.30K	Skr-3.33 Million ≈ $-358.15K	0.797x	+103.33%
2023-12-31	Skr486.00K ≈ $52.30K	Skr-11.64 Million ≈ $-1.25 Million	-23.957x	-758.22%
2022-12-31	Skr3.44 Million ≈ $369.98K	Skr-9.60 Million ≈ $-1.03 Million	-2.791x	-89.90%
2021-12-31	Skr10.96 Million ≈ $1.18 Million	Skr-16.12 Million ≈ $-1.73 Million	-1.470x	-209.74%
2020-12-31	Skr28.85 Million ≈ $3.10 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.475x	-51.21%
2019-12-31	Skr43.59 Million ≈ $4.69 Million	Skr-13.68 Million ≈ $-1.47 Million	-0.314x	+75.16%
2018-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-20.05 Million ≈ $-2.16 Million	-1.264x	-497.58%
2017-12-31	Skr45.76 Million ≈ $4.92 Million	Skr-9.68 Million ≈ $-1.04 Million	-0.211x	+0.97%
2016-12-31	Skr33.19 Million ≈ $3.57 Million	Skr-7.09 Million ≈ $-762.54K	-0.214x	+50.12%
2015-12-31	Skr12.79 Million ≈ $1.38 Million	Skr-5.47 Million ≈ $-588.95K	-0.428x	-141796.96%
2014-12-31	Skr8.63 Million ≈ $929.25K	Skr-2.60K ≈ $-280.32	0.000x	--

About Gabather AB (publ)

ST:GABA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$2.48 Million

Skr23.08 Million SEK

Market Cap Rank

#29715 Global

#684 in Sweden

Share Price

Skr0.04

Change (1 day)

+1.07%

52-Week Range

Skr0.02 - Skr0.08

All Time High

Skr71.87